PL3911347T3 - Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet - Google Patents
Kompozycja do stosowania w leczeniu nietrzymania moczu u kobietInfo
- Publication number
- PL3911347T3 PL3911347T3 PL20700172.8T PL20700172T PL3911347T3 PL 3911347 T3 PL3911347 T3 PL 3911347T3 PL 20700172 T PL20700172 T PL 20700172T PL 3911347 T3 PL3911347 T3 PL 3911347T3
- Authority
- PL
- Poland
- Prior art keywords
- women
- treatment
- composition
- urinary incontinence
- incontinence
- Prior art date
Links
- 206010046543 Urinary incontinence Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1900478A FR3091819B1 (fr) | 2019-01-18 | 2019-01-18 | Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire |
| PCT/EP2020/050671 WO2020148224A1 (fr) | 2019-01-18 | 2020-01-13 | Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3911347T3 true PL3911347T3 (pl) | 2024-02-05 |
Family
ID=66867402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20700172.8T PL3911347T3 (pl) | 2019-01-18 | 2020-01-13 | Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12109246B2 (pl) |
| EP (1) | EP3911347B1 (pl) |
| JP (1) | JP7494186B2 (pl) |
| CN (1) | CN113316456B (pl) |
| AU (1) | AU2020209886B2 (pl) |
| CA (1) | CA3123859A1 (pl) |
| DK (1) | DK3911347T3 (pl) |
| ES (1) | ES2966149T3 (pl) |
| FR (1) | FR3091819B1 (pl) |
| MX (1) | MX2021008602A (pl) |
| PL (1) | PL3911347T3 (pl) |
| PT (1) | PT3911347T (pl) |
| WO (1) | WO2020148224A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000027423A1 (it) * | 2020-11-16 | 2022-05-16 | Kolinpharma S P A | Composizione multicomponente e suo uso nel trattamento di patologie della prostata |
| CA3212328C (en) | 2021-03-16 | 2024-11-05 | Aalto University Foundation Sr | COMPOSITION INTENDED FOR USE IN THE TREATMENT OF URINARY OR FECAL INCONTINENCE |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5690102B2 (ja) * | 2010-08-28 | 2015-03-25 | アサマ化成株式会社 | 泌尿器系疾患予防治療用組成物及びその製造方法 |
| FR3055215B1 (fr) * | 2016-08-31 | 2020-02-14 | S.A.M. Serelys Pharma | Composition comprenant des extraits de pollen et /ou de pistils |
| FR3068605B1 (fr) * | 2017-07-10 | 2020-02-21 | Serelys Pharma S.A.M. | Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire |
| FR3070263B1 (fr) * | 2017-08-28 | 2020-07-24 | Serelys Pharma S A M | Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite |
-
2019
- 2019-01-18 FR FR1900478A patent/FR3091819B1/fr active Active
-
2020
- 2020-01-13 CA CA3123859A patent/CA3123859A1/fr active Pending
- 2020-01-13 ES ES20700172T patent/ES2966149T3/es active Active
- 2020-01-13 AU AU2020209886A patent/AU2020209886B2/en active Active
- 2020-01-13 PL PL20700172.8T patent/PL3911347T3/pl unknown
- 2020-01-13 WO PCT/EP2020/050671 patent/WO2020148224A1/fr not_active Ceased
- 2020-01-13 EP EP20700172.8A patent/EP3911347B1/fr active Active
- 2020-01-13 PT PT207001728T patent/PT3911347T/pt unknown
- 2020-01-13 CN CN202080009962.7A patent/CN113316456B/zh active Active
- 2020-01-13 MX MX2021008602A patent/MX2021008602A/es unknown
- 2020-01-13 JP JP2021541526A patent/JP7494186B2/ja active Active
- 2020-01-13 DK DK20700172.8T patent/DK3911347T3/da active
- 2020-01-13 US US17/365,055 patent/US12109246B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020148224A1 (fr) | 2020-07-23 |
| FR3091819B1 (fr) | 2021-04-23 |
| US20230149498A1 (en) | 2023-05-18 |
| CN113316456A (zh) | 2021-08-27 |
| JP2022522997A (ja) | 2022-04-21 |
| CN113316456B (zh) | 2024-05-14 |
| US12109246B2 (en) | 2024-10-08 |
| FR3091819A1 (fr) | 2020-07-24 |
| ES2966149T3 (es) | 2024-04-18 |
| CA3123859A1 (fr) | 2020-07-23 |
| AU2020209886B2 (en) | 2025-01-23 |
| EP3911347A1 (fr) | 2021-11-24 |
| BR112021013006A2 (pt) | 2021-09-14 |
| MX2021008602A (es) | 2021-09-21 |
| DK3911347T3 (da) | 2023-11-13 |
| JP7494186B2 (ja) | 2024-06-03 |
| PT3911347T (pt) | 2023-12-11 |
| EP3911347B1 (fr) | 2023-10-04 |
| BR112021013006A8 (pt) | 2023-04-11 |
| AU2020209886A1 (en) | 2021-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297849B1 (en) | Composition for use in the treatment of APOL1-related disease | |
| IL290415A (en) | Compounds with deuterium for use in cancer treatment | |
| PL4076461T3 (pl) | Lumateperon do stosowania w leczeniu schizofrenii | |
| EP3744347A4 (en) | COMPOSITION FOR USE IN THE TREATMENT OF SKIN DISEASES | |
| IL287464A (en) | Anti-cd40 antibodies for use in the treatment of t1dm and insulitis | |
| GB202012330D0 (en) | Liquid dressing compositions and their veterinary uses | |
| SI4340842T1 (sl) | Sotorasib za uporabo pri zdravljenju raka | |
| ZA202107235B (en) | Compositions and methods for treating ocular disease | |
| PL3793497T3 (pl) | Artykuł na inkontynencję w postaci pieluchomajtek | |
| GB201918414D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
| IL309172A (en) | Vulbanazine for use in the additional treatment of schizophrenia | |
| GB2595089B (en) | Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping | |
| DK3911347T3 (da) | Sammensætning til anvendelse i behandlingen af urininkontinens hos kvinder | |
| GB2591598B (en) | Composition for the treatment of urinary tract infections | |
| EP3781262A4 (en) | COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASE IN SELECTED PATIENTS | |
| IL288307A (en) | Preparations for use in the treatment of insulin deficiency conditions | |
| PL4304667T3 (pl) | Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału | |
| GB202002299D0 (en) | Agents for use in the treatment of tissue damage | |
| GB201908076D0 (en) | Skin treatment composition | |
| IL271180A (en) | Methods for preventing and treating urinary incontinence | |
| HK40087155A (en) | Composition for use in the treatment of apol1-associated disease | |
| HK40074743A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| GB202019103D0 (en) | Device for the treatment of stress urinary incontinence | |
| GB201918539D0 (en) | Compounds for use in treatment and prophylaxis | |
| GB202302121D0 (en) | Compounds for use in the treatment of schizophrenia |